Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals - ECDC PPS validation protocol version 3.1.2.

Technical report
Cite:
Citation Link

European Centre for Disease Prevention and Control. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – ECDC PPS validation protocol version 3.1.2. Stockholm: ECDC; 2019. 

Copy citation to clipboard

The current protocol version 3.2.1 is the ECDC PPS validation protocol used during the second EU-wide PPS of HAIs and antimicrobial use in 2016–2017. This protocol version is an accompanying document to the ECDC protocol for the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals version 5.3.

Read more on this site

About ECDC Point prevalence survey

The ECDC point prevalence survey estimates the total burden (prevalence) of HAI and antimicrobial use in acute care hospitals in the EU and describes patients, invasive procedures, infections (sites, microorganisms including markers for antimicrobial resistance) and prescribed antimicrobials

Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – protocol version 5.3

Version 5.3 is the final protocol for the second EU-wide point prevalence survey (PPS 2016–2017). It contains major changes compared to protocol version 4.3 (PPS 2011–2012). Compared to versions 5.1 (January 2016) and 5.2 (May 2016), the current version only contains a few corrections, editorial changes and clarifications.

Related updates on antimicrobial resistance (AMR) and healthcare-associated infections

News

Less and more appropriate antibiotic use needed to reduce antibiotic resistance

Press release -

News

ECDC Rapid Risk Assessment: Several recent COVID-19 outbreaks in long-term care facilities in the EU/EEA

News story -

Publication

Rapid Risk Assessment: COVID-19 outbreaks in long-term care facilities in the EU/EEA in the context of current vaccination coverage

Risk assessment -

Publication

Rapid risk assessment: Increase in OXA-244 -producing Escherichia coli in the European Union/European Economic Area and the UK since 2013, first update

Risk assessment -

Data

EARS-Net Reporting protocol 2021

Tool -